Anxiety and depression are more common among people with Crohn’s disease, and they can worsen symptoms. Here’s why and ways ...

Patients with inflammatory bowel disease (IBD) continue to experience barriers to health care access and treatment and financial struggles.

Enterostomal therapy is a specialized type of care provided to patients with ... For patients who have a stoma as a result of ...

In a world first, researchers at the Kennedy Institute, Oxford have mapped the cellular dynamics following treatment with the ...

NImmune Biopharma ("NImmune”), a private late-clinical-stage precision inflammation and immunology (“I&I”) biopharmaceutical company developing novel biomarker-driven immunoregulatory therapeutics, ...

Oxford researchers have discovered why some patients benefit from the most commonly used advanced therapy in autoimmune diseases and some do not.

In the realm of gastroenterology, inflammatory bowel disease (IBD), encompassing Crohn’s disease (CD) and ulcerative colitis ...

In a world first, researchers have mapped the cellular dynamics following treatment with the most commonly used advanced ...

Researchers from Phoenixlab, The Scripps Research Institute and affiliated organizations presented the discovery of a novel bivalent protease-activated receptor PAR1- and PAR3-derived peptide, named ...

To expand access to care for patients, Cleveland Clinic has added Ayble Health, an AI-enabled digital care platform, to its ...